These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28791015)

  • 1. Influence of Irradiated Peripheral Blood Mononuclear Cells on Both
    Delso-Vallejo M; Kollet J; Koehl U; Huppert V
    Front Immunol; 2017; 8():854. PubMed ID: 28791015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers.
    Kim EK; Ahn YO; Kim S; Kim TM; Keam B; Heo DS
    Cytotherapy; 2013 Feb; 15(2):231-241.e1. PubMed ID: 23321334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of natural killer cells using cryopreserved irradiated feeder cells.
    Baek HJ; Kim JS; Yoon M; Lee JJ; Shin MG; Ryang DW; Kook H; Kim SK; Cho D
    Anticancer Res; 2013 May; 33(5):2011-9. PubMed ID: 23645750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irradiated and activated autologous PBMCs induce expansion of highly cytotoxic human NK cells in vitro.
    Ahn YO; Kim S; Kim TM; Song EY; Park MH; Heo DS
    J Immunother; 2013 Sep; 36(7):373-81. PubMed ID: 23924789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor.
    Sutlu T; Stellan B; Gilljam M; Quezada HC; Nahi H; Gahrton G; Alici E
    Cytotherapy; 2010 Dec; 12(8):1044-55. PubMed ID: 20795758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer.
    Razmara AM; Farley LE; Harris RM; Judge SJ; Lammers M; Iranpur KR; Johnson EG; Dunai C; Murphy WJ; Brown CT; Rebhun RB; Kent MS; Canter RJ
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriers.
    Todorovic M; Mesiano G; Gammaitoni L; Leuci V; Giraudo Diego L; Cammarata C; Jordaney N; Carnevale-Schianca F; Gallo S; Fagioli F; Piacibello W; Elia AR; Pignochino Y; Dell'aglio C; Grignani G; Cignetti A; Aglietta M; Sangiolo D
    J Immunother; 2012 Sep; 35(7):579-86. PubMed ID: 22892454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and expansion of natural killer cells for NK cell-based immunotherapy.
    Becker PS; Suck G; Nowakowska P; Ullrich E; Seifried E; Bader P; Tonn T; Seidl C
    Cancer Immunol Immunother; 2016 Apr; 65(4):477-84. PubMed ID: 26810567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shaping of Natural Killer Cell Antitumor Activity by
    Granzin M; Wagner J; Köhl U; Cerwenka A; Huppert V; Ullrich E
    Front Immunol; 2017; 8():458. PubMed ID: 28491060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy.
    Lim SA; Kim TJ; Lee JE; Sonn CH; Kim K; Kim J; Choi JG; Choi IK; Yun CO; Kim JH; Yee C; Kumar V; Lee KM
    Cancer Res; 2013 Apr; 73(8):2598-607. PubMed ID: 23580577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of autologous dendritic cells on the in-vitro expansion and functions of peripheral blood NK cells.
    Li XH; Wu XX; Wu YM; Da WM; Li M; Cai B; Zhao XL; Dou LP; Gao CJ
    Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):72-80. PubMed ID: 25409754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly efficient IL-21 and feeder cell-driven
    Granzin M; Stojanovic A; Miller M; Childs R; Huppert V; Cerwenka A
    Oncoimmunology; 2016; 5(9):e1219007. PubMed ID: 27757317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple effects of IL-21 on human NK cells in ex vivo expansion.
    Li Q; Ye LJ; Ren HL; Huyan T; Li J; Shi JL; Huang QS
    Immunobiology; 2015 Jul; 220(7):876-88. PubMed ID: 25758713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
    Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
    J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of highly cytotoxic natural killer cells for treatment of acute myelogenous leukemia using a feeder-free, particle-based approach.
    Oyer JL; Igarashi RY; Kulikowski AR; Colosimo DA; Solh MM; Zakari A; Khaled YA; Altomare DA; Copik AJ
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):632-9. PubMed ID: 25576425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
    Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
    Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous natural killer cell therapy for human recurrent malignant glioma.
    Ishikawa E; Tsuboi K; Saijo K; Harada H; Takano S; Nose T; Ohno T
    Anticancer Res; 2004; 24(3b):1861-71. PubMed ID: 15274367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-21 induces proliferation and modulates receptor expression and effector function in canine natural killer cells.
    Shin DJ; Lee SH; Park JY; Kim JS; Lee JJ; Suh GH; Lee YK; Cho D; Kim SK
    Vet Immunol Immunopathol; 2015 May; 165(1-2):22-33. PubMed ID: 25819349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Ex Vivo Method for Effective Expansion and Activation of Human Natural Killer Cells for Anti-Tumor Immunotherapy.
    Yang H; Tang R; Li J; Liu Y; Ye L; Shao D; Jin M; Huang Q; Shi J
    Cell Biochem Biophys; 2015 Dec; 73(3):723-9. PubMed ID: 27259316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.